vancomycin has been researched along with tedizolid in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (20.00) | 29.6817 |
2010's | 10 (66.67) | 24.3611 |
2020's | 2 (13.33) | 2.80 |
Authors | Studies |
---|---|
Brown-Driver, V; Finn, J; Pillar, CM; Poppe, S; Schaadt, R; Shaw, KJ; Shinabarger, D; Zurenko, G | 1 |
Schaadt, R; Shinabarger, D; Sweeney, D; Zurenko, G | 1 |
Hilgers, M; Locke, JB; Shaw, KJ | 1 |
Betriu, C; Culebras, E; Gómez, M; López-Fabal, F; Morales, G; Picazo, JJ; Rodríguez-Avial, I | 1 |
G C, K; Hilgers, M; José Picazo, J; Locke, JB; Morales, G; Rahawi, S; Shaw, KJ; Stein, JL | 1 |
Gordeev, MF; Yuan, ZY | 1 |
Crandon, JL; Hagihara, M; Keel, RA; Nicolau, DP; Tessier, PR | 1 |
Holmes, NE; Howden, BP | 1 |
Arber, M; Barata, T; Eales, J; Fleetwood, K; Glanville, J; Gould, IM; Kauf, TL; McCool, R | 1 |
Abdul Momin, HF; Betts, JW; Phee, LM; Wareham, DW | 1 |
Prince, RA; Raad, II; Reitzel, R; Rolston, KVI; Shelburne, SA; Vargas-Cruz, N | 1 |
Avaca-Crusca, JS; Camargo, ILBDC; Dabul, ANG; Okado, JB; Oliveira, AL | 1 |
Abdelraouf, K; Kidd, JM; Nicolau, DP | 1 |
Chen, YH; Chen, YS; Cheng, SH; Hsueh, PR; Ko, WC; Lee, CM; Lee, WS; Lee, YL; Liao, CH; Lin, CY; Liu, CP; Liu, PY; Lu, MC; Lu, PL; Shao, PL; Sheng, WH; Shi, ZY; Tsai, HY; Tseng, SH; Wang, FD; Wang, LS; Wu, TS; Yen, MY | 1 |
Carvalhaes, CG; Castanheira, M; DeVries, S; Mendes, RE; Rhomberg, PR; Sader, HS | 1 |
3 review(s) available for vancomycin and tedizolid
Article | Year |
---|---|
New potent antibacterial oxazolidinone (MRX-I) with an improved class safety profile.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Bone Marrow Cells; Clinical Trials, Phase I as Topic; Drug Design; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Monoamine Oxidase Inhibitors; Oxazolidinones; Pyridones; Sepsis | 2014 |
What's new in the treatment of serious MRSA infection?
Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Cost-Benefit Analysis; Drug Administration Routes; Drug Therapy, Combination; Glycopeptides; Humans; Linezolid; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Severity of Illness Index; Skin Diseases, Bacterial; Staphylococcal Infections; Tetrazoles; Vancomycin | 2014 |
Systematic review and network meta-analysis of tedizolid for the treatment of acute bacterial skin and skin structure infections caused by MRSA.
Topics: Anti-Bacterial Agents; Bayes Theorem; Ceftaroline; Cephalosporins; Daptomycin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Organophosphates; Oxazoles; Oxazolidinones; Skin Diseases, Bacterial; Staphylococcal Infections; Tetrazoles; Vancomycin | 2017 |
12 other study(ies) available for vancomycin and tedizolid
Article | Year |
---|---|
In vitro activity of TR-700, the antibacterial moiety of the prodrug TR-701, against linezolid-resistant strains.
Topics: Acetamides; Anti-Bacterial Agents; Binding Sites; Drug Resistance, Bacterial; Enterococcus; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Models, Molecular; Oxazolidinones; Prodrugs; Staphylococcus aureus | 2008 |
In vitro activity of TR-700, the active ingredient of the antibacterial prodrug TR-701, a novel oxazolidinone antibacterial agent.
Topics: Anti-Bacterial Agents; Bacteria; Enterococcus; Haemophilus influenzae; Microbial Sensitivity Tests; Moraxella catarrhalis; Oxazolidinones; Staphylococcus; Streptococcus | 2009 |
Mutations in ribosomal protein L3 are associated with oxazolidinone resistance in staphylococci of clinical origin.
Topics: Acetamides; Binding Sites; Drug Resistance, Bacterial; Linezolid; Mutation; Oxazolidinones; Protein Structure, Secondary; Ribosomal Protein L3; Ribosomal Proteins; RNA, Ribosomal, 23S; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Tetrazoles | 2009 |
Comparative activities of TR-700 (torezolid) against staphylococcal blood isolates collected in Spain.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; In Vitro Techniques; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Sepsis; Spain; Staphylococcal Infections; Tetrazoles; Vancomycin | 2010 |
Elevated linezolid resistance in clinical cfr-positive Staphylococcus aureus isolates is associated with co-occurring mutations in ribosomal protein L3.
Topics: Acetamides; Anti-Infective Agents; Bacterial Proteins; Drug Resistance, Bacterial; Linezolid; Methyltransferases; Microbial Sensitivity Tests; Mutation; Oxazolidinones; Ribosomal Protein L3; Ribosomal Proteins; Staphylococcus aureus | 2010 |
Comparative in vivo efficacies of epithelial lining fluid exposures of tedizolid, linezolid, and vancomycin for methicillin-resistant Staphylococcus aureus in a mouse pneumonia model.
Topics: Acetamides; Administration, Oral; Animals; Anti-Bacterial Agents; Colony Count, Microbial; Disease Models, Animal; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Linezolid; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Oxazolidinones; Pneumonia, Staphylococcal; Survival Rate; Tetrazoles; Vancomycin | 2012 |
Comparative activity of tedizolid and glycopeptide combination therapies for the treatment of Staphylococcus aureus infections: an in vitro and in vivo evaluation against strains with reduced susceptibility to glycopeptides.
Topics: Animals; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Larva; Lepidoptera; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Tetrazoles; Vancomycin | 2018 |
In vitro activity of tedizolid and comparator agents against clinical Gram-positive isolates recovered from patients with cancer.
Topics: Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Microbial Viability; Oxazolidinones; Tetrazoles; Vancomycin | 2018 |
Daptomycin and vancomycin heteroresistance revealed among CC5-SCCmecII MRSA clone and in vitro evaluation of treatment alternatives.
Topics: Bacterial Proteins; Bacteriolysis; Brazil; Cell Wall; Daptomycin; Drug Resistance, Bacterial; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Multilocus Sequence Typing; Oxazolidinones; Polymorphism, Single Nucleotide; Staphylococcal Infections; Tetrazoles; Vancomycin | 2018 |
Comparative efficacy of human-simulated epithelial lining fluid exposures of tedizolid, linezolid and vancomycin in neutropenic and immunocompetent murine models of staphylococcal pneumonia.
Topics: Animals; Anti-Bacterial Agents; Colony Count, Microbial; Disease Models, Animal; Female; Linezolid; Lung; Mice, Inbred BALB C; Neutropenia; Oxazolidinones; Pneumonia, Staphylococcal; Protein Synthesis Inhibitors; Tetrazoles; Treatment Outcome; Vancomycin | 2019 |
Antimicrobial susceptibility of bacteremic vancomycin-resistant Enterococcus faecium to eravacycline, omadacycline, lipoglycopeptides, and other comparator antibiotics: Results from the 2019-2020 Nationwide Surveillance of Multicenter Antimicrobial Resist
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Daptomycin; Drug Resistance, Bacterial; Enterococcus faecium; Epidemiological Monitoring; Gram-Positive Bacterial Infections; Humans; Linezolid; Lipoglycopeptides; Microbial Sensitivity Tests; Oxazolidinones; Taiwan; Tetracyclines; Tetrazoles; Tigecycline; Vancomycin; Vancomycin-Resistant Enterococci; Virginiamycin | 2021 |
Activity of Tedizolid and Comparator Agents Against Gram-positive Isolates Causing Skin and Skin Structure Infections in Pediatric Patients in United States Hospitals (2015-2019).
Topics: Adolescent; Adult; Anti-Bacterial Agents; Child; Child, Preschool; Daptomycin; Hospitals; Humans; Infant; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus aureus; Tetrazoles; United States; Vancomycin | 2022 |